Dental Implant with Heart Failure and Pacemaker: Risks, Protocol and Digital Planning
Heart failure, cardiac arrhythmias, and implanted pacemakers or defibrillators (ICD) represent independent risk factors in implant planning — not because of the implant surgery itself, but because of interactions between anticoagulation, endocarditis prophylaxis, and electromagnetic interference from surgical devices. This article explains how IIDZ Vienna systematically evaluates these risks and minimises them with a fully digital protocol.
Clinical relevance: Cardiac patients on anticoagulation (warfarin, NOACs) and/or with an implanted pacemaker/ICD require cardiology clearance and an adapted perioperative protocol before any implant surgery. Electrosurgical devices (electrocautery, monopolar piezo-surgery) can inhibit pacemakers or cause ICD misfiring.
1. Cardiovascular Risk Classification for Implant Planning
The European Society of Cardiology (ESC) and the DGZMK distinguish three risk classes for cardiac patients that directly determine the implant indication and operative protocol:
| Risk Class | Examples | Implant Indication | Key Requirements |
|---|---|---|---|
| Low | Stable CAD, controlled hypertension, compensated HF (NYHA I–II) | Possible with adapted protocol | Anticoagulation management, cardiology clearance recommended |
| Moderate | HF NYHA III, pacemaker, non-critical valve disease | Possible after optimisation | Mandatory: cardiology clearance, pacemaker protocol, endocarditis prophylaxis assessment |
| High | Decompensated HF (NYHA IV), recent MI (< 6 months), critical aortic stenosis, ICD with recurrent shocks | Contraindicated until stabilisation | Implant planning only after cardiology stabilisation and clearance |
Digital implant planning at IIDZ Vienna begins with capturing the complete cardiological status — including current medication, the latest cardiology report, and pacemaker type (manufacturer, model, programming). These data flow directly into the CBCT-based 3D planning and determine which surgical instruments and anaesthesia protocol are used.
2. Anticoagulation and Implant Surgery: Continue or Bridge?
The question of whether anticoagulants should be stopped before implant surgery is clinically settled: stopping increases thromboembolic risk more than the bleeding risk under anticoagulation. Current guidelines (ESC 2022, DGZMK S3 guideline 2021) recommend continuing anticoagulation for most patients undergoing elective dentoalveolar procedures.
| Drug | Class | Recommendation for Implant Surgery | Monitoring |
|---|---|---|---|
| Warfarin / Phenprocoumon | VKA | Continue if INR 2.0–3.5; local haemostasis | INR check on day of surgery |
| Rivaroxaban, Apixaban, Dabigatran | NOAC | Skip dose on day of surgery (12–24 h pause depending on agent); no bridging required | Check renal function (eGFR) |
| Aspirin 100 mg | Antiplatelet | Continue; no relevant bleeding risk for implant surgery | — |
| Dual antiplatelet (ASA + Clopidogrel) | DAPT | Cardiology consultation mandatory; generally continue; reinforce local haemostasis | Cardiology clearance |
In the IIDZ Vienna digital workflow, the anticoagulation class is recorded during the planning phase. Guided implantology with an individually fabricated surgical guide minimises soft-tissue trauma and thus bleeding risk — a direct advantage for anticoagulated patients compared to conventional freehand surgery.
3. Endocarditis Prophylaxis: When Is It Mandatory for Implant Surgery?
Endocarditis prophylaxis is not indicated for all cardiac patients — only for high-risk patients with specific heart conditions. The ESC 2023 guideline defines three high-risk groups for whom antibiotic prophylaxis before implant surgery with mucosal incision is mandatory:
High-risk groups (ESC 2023) — prophylaxis mandatory:
- History of endocarditis
- Cyanotic congenital heart defects (uncorrected or with residual defect)
- Valve replacement (mechanical or biological) and valve reconstruction with foreign material
Standard: Amoxicillin 2 g orally 30–60 min before the procedure; penicillin allergy: Clindamycin 600 mg orally.
Pacemakers and ICDs alone do not justify endocarditis prophylaxis. Patients with a pacemaker but without accompanying valve disease or history of endocarditis do not receive prophylactic antibiotics before implant surgery — a common misconception in clinical practice.
4. Pacemaker, ICD and Electromagnetic Interference During Implant Surgery
| Device | Interference Risk | Recommendation for Pacemaker/ICD |
|---|---|---|
| Monopolar electrocautery | High | Contraindicated with pacemaker/ICD |
| Bipolar electrocautery | Low | Acceptable; keep electrodes close together |
| Piezo-surgery (monopolar mode) | Low to moderate | Prefer bipolar mode; consult cardiologist |
| Laser (Er:YAG, diode) | Minimal | Safe to use |
| Implant motor (rotary) | Minimal | Safe to use |
Important: For ICD patients, it should be discussed with the cardiologist before elective procedures whether the ICD can be temporarily switched to "sensing-only" mode. This prevents accidental shock delivery due to artefacts. Reprogramming must be performed by the cardiologist and reversed immediately after the procedure.
5. The IIDZ Vienna 6-Step Digital Protocol for Cardiac Patients
Cardiological screening and risk classification
Digital capture of complete cardiac status: diagnoses, medication (incl. anticoagulants, antiarrhythmics), pacemaker/ICD type (manufacturer, model, implantation date, last check). Risk classification per ESC scheme.
CBCT diagnostics and 3D planning with bone quality analysis
Low-dose CBCT with digital bone density measurement (Hounsfield units). In cardiac patients with reduced bone quality (common under long-term diuretics or in heart failure), implant position and length are adjusted accordingly.
Cardiology clearance and anticoagulation management
Standardised clearance form for the cardiologist with all relevant information (procedure, duration, planned instruments, anaesthesia). Anticoagulation protocol per current guideline.
Guided surgery — surgical guide from digital workflow
CAD/CAM-fabricated surgical guide based on 3D planning. Minimises operating time, soft-tissue trauma and bleeding risk — particularly relevant for anticoagulated patients. No monopolar electrocautery; bipolar mode or laser if needed.
Perioperative monitoring and emergency protocol
Continuous pulse oximetry and ECG monitoring during surgery. Emergency protocol for pacemaker inhibition and ICD malfunction in place. Defibrillator available in the treatment room.
Digital aftercare with shortened recall intervals
Closer recall intervals (3 instead of 6 months) in the first year. Digital peri-implantitis early detection via standardised probing depth measurement. Coordination with cardiologist if abnormalities arise.
Conclusion: Cardiac patients can receive implants — with the right protocol
Heart failure and pacemakers are not general contraindications for dental implants. What matters is systematic risk classification, correct anticoagulation management, endocarditis prophylaxis for high-risk patients, and avoiding monopolar electrosurgery. The IIDZ Vienna digital protocol — from CBCT planning through CAD/CAM surgical guides to close digital aftercare — minimises operative risks and enables safe implant treatment even for cardiovascularly compromised patients.
IIDZ Wien – Wissenschaftliche Redaktion
Wissenschaftliche Redaktion
Weitere Artikel
Thematisch verwandt
Hinweis: Diese Inhalte dienen ausschließlich der allgemeinen Information und ersetzen keine individuelle zahnärztliche Beratung. Das Institut für Implantologie und digitale Zahnmedizin Wien ist eine gemeinnützige, unabhängige Wissenschaftsplattform — kein Behandlungsbetrieb. Alle Angaben entsprechen dem aktuellen Stand der wissenschaftlichen Literatur; individuelle Behandlungsentscheidungen müssen stets mit einem approbierten Zahnarzt oder Facharzt getroffen werden.